Echinocandins Versus Azoles for Candidemia Treatment

CompletedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

February 1, 2019

Study Completion Date

September 1, 2019

Conditions
Candidemia
Interventions
DRUG

Echinocandin treatment

Patients received echinocandins as a first-line therapy after candidemia diagnosis according to the standard of care

DRUG

Triazole treatment

"Patients received triazoles as a first-line therapy after candidemia diagnosis according to the standard of care.~Candidemia was defined as at least one blood culture positive for Candida."

Trial Locations (1)

69004

Hospices Civils de Lyon, Hôpital de la Croix-Rousse, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03799172 - Echinocandins Versus Azoles for Candidemia Treatment | Biotech Hunter | Biotech Hunter